{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:21:32Z","timestamp":1789410092239,"version":"build-2803163510"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/bor.0b013e3282efdc7c","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T03:01:09Z","timestamp":1191466869000},"page":"550-559","source":"Crossref","is-referenced-by-count":76,"title":["Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis"],"prefix":"10.1097","volume":"19","author":[{"given":"Valerie","family":"Askanas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W King","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/01.wnl.0000192260.33106.bb","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis: diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jemt.20186","article-title":"Molecular pathology and pathogenesis of inclusion-body myositis","volume":"67","author":"Askanas","year":"2005","journal-title":"Microsc Res Tech"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00401-006-0113-5","article-title":"Schroder, Deckert M. The inflammatory reaction pattern distinguishes primary dysferlinopathies from idiopathic inflammatory myopathies: an important role for the membrane attack complex.","volume":"112","author":"Brunn","year":"2006","journal-title":"Acta Neuropathol"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","article-title":"Endoplasmic reticulum stress and unfolded protein response in inclusion body-myositis muscle","volume":"164","author":"Vattemi","year":"2004","journal-title":"Am J Pathol"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1126\/science.7545313","article-title":"A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides","volume":"269","author":"Suto","year":"1995","journal-title":"Science"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.186.8.1315","article-title":"Heat shock protein\u2013peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity","volume":"186","author":"Blachere","year":"1997","journal-title":"J Exp Med"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0198-8859(01)00269-5","article-title":"Major histocompatibility class one molecule associates with glucose regulated protein (GRP) 78 on the cell surface","volume":"62","author":"Triantafilou","year":"2001","journal-title":"Hum Immunol"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.182.3.885","article-title":"Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96","volume":"182","author":"Arnold","year":"1995","journal-title":"J Exp Med"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","article-title":"Genetically augmenting A\u03b242 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice","volume":"168","author":"Kitazawa","year":"2006","journal-title":"Am J Pathol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0960-8966(03)00140-8","article-title":"A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation","volume":"13","author":"Krause","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2005.01.012","article-title":"Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy","volume":"15","author":"Amouri","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.21115","article-title":"\u03b2-Amyloid is a substrate of autophagy in sporadic inclusion body myositis","volume":"61","author":"L\u00fcnemann","year":"2007","journal-title":"Ann Neurol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"16995","DOI":"10.1073\/pnas.0603386103","article-title":"MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle","volume":"103","author":"Morosetti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/60.1.1","article-title":"Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease","volume":"60","author":"Askanas","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002281-200311000-00009","article-title":"Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-\u03b2, misfolded proteins, predisposing genes, and aging","volume":"15","author":"Askanas","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001756-199810050-00013","article-title":"Impaired innervation of cultured human muscle overexpressing \u03b2APP experimentally and genetically: relevance to inclusion-body myopathies","volume":"9","author":"McFerrin","year":"1998","journal-title":"Neuroreport"},{"key":"R23-6-20210128","first-page":"240","article-title":"Ultrastructural abnormalities of neuromuscular junctions in sporadic inclusion-body myositis","volume":"54","author":"Alvarez","year":"2000","journal-title":"Neurol"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","article-title":"Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers","volume":"167","author":"Fratta","year":"2005","journal-title":"Am J Pathol"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2990.2006.00821.x","article-title":"Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model","volume":"33","author":"Wojcik","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-005-1035-3","article-title":"Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers","volume":"110","author":"Wojcik","year":"2005","journal-title":"Acta Neuropathol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/ddl446","article-title":"A GNE knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0002-9440(10)65681-7","article-title":"Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis","volume":"153","author":"Jin","year":"1998","journal-title":"Am J Pathol"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0002-9440(10)65682-9","article-title":"Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy","volume":"153","author":"Fukuchi","year":"1998","journal-title":"Am J Pathol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1073\/pnas.082545599","article-title":"Inclusion body myositis-like phenotype induced by transgenic overexpression of \u03b2APP in skeletal muscle","volume":"99","author":"Sugarman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-6-20210128","first-page":"333","article-title":"Amyloid-\u03b242 is preferentially deposited in muscle biopsies of patients with sporadic inclusion-body myositis (s-IBM)","volume":"60","author":"Vattemi","year":"2003","journal-title":"Neurology"},{"key":"R32-6-20210128","first-page":"A464","article-title":"Novel proposed role of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2i) in the pathogenesis of inclusion-body myositis (IBM)","volume":"56","author":"Wilczynski","year":"2001","journal-title":"Neurol"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(00)01485-3","article-title":"Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation","volume":"293","author":"Wilczynski","year":"2000","journal-title":"Neurosci Lett"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1023\/A:1026065122854","article-title":"Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman","volume":"28","author":"Selkoe","year":"2003","journal-title":"Neurochem Res"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)65680-5","article-title":"Does overexpression of BetaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease","volume":"153","author":"Askanas","year":"1998","journal-title":"Am J Pathol"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-\u03b2 in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00001756-199306000-00055","article-title":"\u03b2-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle","volume":"4","author":"Sarkozi","year":"1993","journal-title":"Neuroreport"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.expneurol.2006.12.014","article-title":"Endoplasmic reticulum stress induces myostatin precursor protein and NF-\u03baB in cultured human muscle fibers: relevance to inclusion-body myositis","volume":"204","author":"Nogalska","year":"2007","journal-title":"Exp Neurol"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"Sinha","year":"1999","journal-title":"Nature"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(01)06969-0","article-title":"Presence of BACE1 and BACE 2 in muscle fibres of patients with sporadic inclusion-body myositis","volume":"358","author":"Vattemi","year":"2001","journal-title":"Lancet"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-4886(02)00025-0","article-title":"BACE1 and BACE2 in pathologic and normal human muscle","volume":"179","author":"Vattemi","year":"2003","journal-title":"Exp Neurol"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn785","article-title":"Gamma-secretase, Notch, Abeta, and Alzheimer's disease: where do the presenilins fit in?","volume":"3","author":"Sisodia","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"R44-6-20210128","first-page":"315","article-title":"Nicastrin, a novel protein participating in amyloid-\u03b2 production, is overexpressed in sporadic inclusion-body myositis muscle","volume":"60","author":"Vattemi","year":"2003","journal-title":"Neurology"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.58.3.438","article-title":"Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle","volume":"58","author":"Jaworska-Wilczynska","year":"2002","journal-title":"Neurology"},{"key":"R46-6-20210128","first-page":"210","article-title":"Cholesterol and caveolae: structural and functional relationships","volume":"1529","author":"Fielding","year":"2000","journal-title":"Biochem Biophys Acta"},{"key":"R47-6-20210128","first-page":"489","article-title":"Combined influence of amyloid-\u03b2 precursor protein (A\u03b2PP) gene transfer and cholesterol excess on cultured normal human muscle fibers","volume":"58","author":"McFerrin","year":"2002","journal-title":"Neurology"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jnen\/60.1.94","article-title":"Co-deposition of cystatin C with amyloid-beta protein in the brain of Alzheimer-disease patients","volume":"60","author":"Levy","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1046\/j.1471-4159.2003.01798.x","article-title":"Cystatin C colocalizes with amyloid-\u03b2 and co-immunoprecipitates with amyloid-\u03b2 precursor protein in sporadic inclusion-body myositis muscle","volume":"85","author":"Vattemi","year":"2003","journal-title":"J Neurochem"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1074\/jbc.275.12.8703","article-title":"Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2","volume":"275","author":"Choi","year":"2000","journal-title":"J Biol Chem"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2353\/ajpath.2007.070105","article-title":"Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy","volume":"171","author":"Farris","year":"2007","journal-title":"Am J Pathol"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1471-4159.2005.03584.x","article-title":"Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis","volume":"96","author":"Broccolini","year":"2006","journal-title":"J Neurochem"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jnen\/63.6.650","article-title":"Insulin-like growth factor 1 in inclusion-body myositis and human muscle cultures","volume":"63","author":"Broccolini","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"R54-6-20210128","first-page":"A150","article-title":"In sporadic inclusion-body myositis (s-IBM) muscle fibers, NOGO-B might play a novel protective role in inhibiting the abnormal processing of amyloid-\u03b2 precursor protein (A\u03b2PP)","volume":"66","author":"Wojcik","year":"2006","journal-title":"Neurol"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0197-4580(01)00312-8","article-title":"ADDLs and protofibrils: the missing links?","volume":"23","author":"Klein","year":"2002","journal-title":"Neurobiol Aging"},{"key":"R56-6-20210128","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"R57-6-20210128","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1212\/01.wnl.0000192103.24796.42","article-title":"Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis","volume":"66","author":"Glabe","year":"2006","journal-title":"Neurology"},{"key":"R58-6-20210128","first-page":"1","article-title":"A\u03b2 oligomers: a decade of discovery","volume":"10","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"R59-6-20210128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1179\/016164105X49436","article-title":"Physiochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease","volume":"27","author":"Watson","year":"2005","journal-title":"Neurol Res"},{"key":"R60-6-20210128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1350-9462(98)00030-5","article-title":"Alpha-crystallin as a molecular chaperone","volume":"18","author":"Derham","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"R61-6-20210128","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1111\/j.1742-4658.2005.04708.x","article-title":"The small heat shock proteins and their role in human disease","volume":"272","author":"Yu","year":"2005","journal-title":"FEBS J"},{"key":"R62-6-20210128","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/BJ20050339","article-title":"\u03b1B-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid-\u03b2 peptide and beta2 microglobulin","volume":"392","author":"Raman","year":"2005","journal-title":"Biochem J"},{"key":"R63-6-20210128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/bbrc.1999.1167","article-title":"The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity","volume":"262","author":"Stege","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R64-6-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.nmd.2006.08.009","article-title":"AbetaPP-overexpression and proteasome inhibition increase \u03b1B-crystallin in cultured human muscle: relevance to inclusion-body myositis","volume":"16","author":"Wojcik","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"R65-6-20210128","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00005072-199607000-00003","article-title":"Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies","volume":"55","author":"Mirabella","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"R66-6-20210128","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"R67-6-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson's disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"R68-6-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10","author":"Bossy-Wetzel","year":"2004","journal-title":"Nat Med"},{"key":"R69-6-20210128","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J Biol Chem"},{"key":"R70-6-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","article-title":"Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"4","author":"Hashimoto","year":"2003","journal-title":"Neuromol Med"},{"key":"R71-6-20210128","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnen\/59.7.592","article-title":"Novel immunolocalization of \u03b1-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions","volume":"59","author":"Askanas","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"R72-6-20210128","first-page":"13","article-title":"Parkin and its association with \u03b1-synuclein and A\u03b2PP in inclusion-body myositis and A\u03b2PP over-expressing cultured human muscle fibers","volume":"25","author":"Paciello","year":"2006","journal-title":"Acta Myologica"},{"key":"R73-6-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"R74-6-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001756-199612200-00031","article-title":"Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis","volume":"8","author":"Yang","year":"1996","journal-title":"Neuroreport"},{"key":"R75-6-20210128","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","article-title":"Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies","volume":"160","author":"Schlossmacher","year":"2002","journal-title":"Am J Pathol"},{"key":"R76-6-20210128","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.M212235200","article-title":"Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function","volume":"278","author":"Tsai","year":"2003","journal-title":"J Biol Chem"},{"key":"R77-6-20210128","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2000","journal-title":"J Biol Chem"},{"key":"R78-6-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mco.0000134365.99523.7f","article-title":"Role of myostatin in metabolism","volume":"7","author":"Gonzalez-Cadavid","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R79-6-20210128","first-page":"121","article-title":"Parkinson-disease-associated DJ-1 is oxidized and might play a novel pathogenic role in sporadic inclusion-body myositis (s-IBM) muscle fibers","volume":"69","author":"Terracciano","year":"2007","journal-title":"Neurology"},{"key":"R80-6-20210128","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J Biol Chem"},{"key":"R81-6-20210128","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/hmg\/ddi134","article-title":"The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis","volume":"14","author":"Xu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R82-6-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"R83-6-20210128","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/ddi211","article-title":"Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis","volume":"14","author":"Zhang","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R84-6-20210128","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"R85-6-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.279.5348.242","article-title":"Frameshift mutants of \u03b2-amyloid precursor protein and ubiquitin in Alzheimer's and Down patients","volume":"279","author":"van Leeuwen","year":"1998","journal-title":"Science"},{"key":"R86-6-20210128","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.03-0205com","article-title":"Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J"},{"key":"R87-6-20210128","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/01.WNL.0000138574.56908.5D","article-title":"Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers","volume":"63","author":"Fratta","year":"2004","journal-title":"Neurology"},{"key":"R88-6-20210128","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol"},{"key":"R89-6-20210128","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1212\/01.wnl.0000192306.98198.ec","article-title":"The unfolded protein response: a stress signaling pathway critical for health and disease","volume":"66","author":"Zhang","year":"2006","journal-title":"Neurology"},{"key":"R90-6-20210128","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.03668.x","article-title":"Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers","volume":"96","author":"Nogalska","year":"2006","journal-title":"J Neurochem"},{"key":"R91-6-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneur.1979.00500420039003","article-title":"Dagen Des Oordeels: pathokinetic mechanisms and molecular messages (a dramatic view)","volume":"36","author":"Engel","year":"1979","journal-title":"Arch Neurol"},{"key":"R92-6-20210128","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/01.wnl.0000192127.63013.8d","article-title":"Mitochondrial abnormalities in inclusion-body myositis","volume":"66","author":"Oldfors","year":"2006","journal-title":"Neurol"},{"key":"R93-6-20210128","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1073\/pnas.93.3.1314","article-title":"Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle","volume":"93","author":"Askanas","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R94-6-20210128","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11064-007-9336-7","article-title":"Amyloid-\u03b2-peptide reduces the expression level of mitochondrial cytochrome oxidase subunits","volume":"32","author":"Hong","year":"2007","journal-title":"Neurochem Res"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282efdc7c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:49:56Z","timestamp":1786034996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200711000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282efdc7c","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}